Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Valerie A. Fritsch is active.

Publication


Featured researches published by Valerie A. Fritsch.


Annals of Otology, Rhinology, and Laryngology | 2014

Spindle Cell Carcinoma of the Upper Aerodigestive Tract An Analysis of 341 Cases With Comparison to Conventional Squamous Cell Carcinoma

Daniel Gerry; Valerie A. Fritsch; Eric J. Lentsch

Objectives: We sought to better characterize spindle cell carcinoma (SpCC) of the upper aerodigestive tract, a rare and aggressive variant, through comparison of a large cohort of head and neck SpCCs against a cohort of conventional head and neck squamous cell carcinoma (SCC) patients. Methods: We compared epidemiologic and clinicopathologic characteristics of 341 SpCCs with 67 882 SCCs of the head and neck, drawing data from the SEER national database. We also compared disease-specific survivals (DSS) for SpCC and SCC based on tumor site and mode of treatment. Results: SpCCs were predominantly laryngeal (46.4%, P < .001) and were more likely to be high grade (P > .001). SpCCs were also more likely than SCCs to present at an early stage (P < .001 to P < .05). Rates of distant metastasis were similar between the tumor types. DSS was similar between SpCCs and SCCs, although site-specific survival rates were higher for SpCCs of the larynx (P = .017) and lower for those of the oral cavity (P = .008). Conclusion: SpCC of the head and neck is more likely than SCC to present at an early stage, with fewer nodal metastases. Survival rates appear to depend on anatomic site as well.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2014

Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival.

Valerie A. Fritsch; E. Ramsay Camp; Eric J. Lentsch

The effect of sentinel lymph node status on survival in patients with Merkel cell carcinoma (MCC) of the head and neck is uncertain.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2014

Basaloid squamous cell carcinoma of the larynx: Analysis of 145 cases with comparison to conventional squamous cell carcinoma

Valerie A. Fritsch; Eric J. Lentsch

Basaloid squamous cell carcinoma (BSCC) is a rare subtype squamous cell carcinoma (SCC) that frequently occurs in the larynx. BSCC is generally considered an aggressive SCC variant; however, because of its rarity, most studies are underpowered to detect statistical differences in disease‐specific survival (DSS).


Laryngoscope | 2014

Basaloid squamous cell carcinoma of the oral cavity: An analysis of 92 cases

Valerie A. Fritsch; Daniel R. Gerry; Eric J. Lentsch

Basaloid squamous cell carcinoma (BSCC) is considered a rare and possibly more aggressive squamous cell carcinoma (SCC) variant. Until now, a series of exclusively oral cavity BSCC patients has not been previously reported. We endeavored to compare BSCC and SCC of the oral cavity, focusing on epidemiologic factors and survival outcomes.


Journal of Surgical Oncology | 2014

Basaloid squamous cell carcinoma of the head and neck: Location means everything

Valerie A. Fritsch; Eric J. Lentsch

Head and neck basaloid squamous cell carcinoma (BSCC) is increasingly recognized as a malignancy with an evolving duel behavior. Our objective was to describe the site‐specific presentation and prognosis of head and neck BSCC in comparison to conventional‐type squamous cell carcinoma (SCC) using population‐based data.


Otolaryngology-Head and Neck Surgery | 2016

Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck

Valerie A. Fritsch; Joan E. Cunningham; Eric J. Lentsch

Objective Theoretically, completion lymph node dissection (CNLD) should have the lowest benefit in the absence of nonsentinel lymph node (NSLN) metastases. For this reason, substantial research efforts have attempted to define specific criteria that are associated with a low-enough risk of NSLN positivity so that CLND can be deferred. Our objectives were (1) to identify features associated with low risk of NSLN positivity in sentinel lymph node–positive cutaneous melanoma of the head and neck (CMHN) and (2) to analyze the effect of CLND on 5-year disease-specific survival (DSS) among subgroups stratified by risk of NSLN metastasis. Study Design Retrospective analysis of population-based data. Setting SEER database. Subjects and Methods Patients with sentinel lymph node–positive CMHN were categorized according to lymph node treatment following sentinel lymph node biopsy (SLNB): 210 underwent CLND and 140 deferred. Clinicopathologic characteristics and survival were compared between SLNB+CLND and SLNB-only groups. Survival analyses were stratified by age and characteristics associated with NSLN positivity. Results Minimal tumor thickness and nonulceration were associated with lowest risk of positive NSLN (P < .025). In the subgroup with the lowest risk of metastasis, patients aged <60 years who underwent CLND+SLNB had markedly better DSS than those receiving SLNB only (>90% vs <25%; P < .0025). Paradoxically, in subgroups with a higher risk of NSLN metastasis, DSS was similar whether CLND was performed or not (P > .25). Conclusions Selecting patients for CLND according to risk of NSLN metastasis may be a suboptimal strategy for improving DSS. We believe that CLND should not be withheld on the basis of “low risk” features in CMHN.


Otolaryngology-Head and Neck Surgery | 2013

Basaloid Squamous Cell Carcinoma of the Oropharynx An Analysis of 650 Cases

Valerie A. Fritsch; Eric J. Lentsch

Objective Basaloid squamous cell carcinoma (BSCC) is considered an aggressive squamous cell carcinoma (SCC) variant. However, we hypothesized that BSCC of the oropharynx may carry a similar prognosis to SCC. A series of exclusively oropharyngeal BSCC patients has not been previously reported. Our objective was to describe the clinical presentation and prognosis of BSCC in a large series of patients with BSCC of the oropharynx and to compare these with a series of patients with conventional-type oropharyngeal SCC. Study Design Retrospective analysis of population-based data. Setting Data reported by the Surveillance, Epidemiology, and End Results (SEER) program are based on medical records of patients who are treated at academic medical centers, community and county hospitals, and health maintenance organizations. Subjects and Methods Clinicopathologic data and disease-specific survival (DSS) were compared between 650 patients with oropharyngeal BSCC and 19,484 with SCC. Results High-grade tumors and nodal metastasis were more common in the BSCC group (P < .02). On multivariable analysis controlling for disease stage, BSCC patients had improved DSS (P < .001). More BSCC patients received multimodality treatment (P < .001). Disease-specific survival was similar in BSCC and SCC patients who were treated with primary surgery; however, among patients who received radiotherapy, DSS was better for those with BSCC (P < .04). Conclusion Analysis of the largest oropharyngeal BSCC series to date demonstrates that BSCC of the oropharynx carries a more favorable prognosis than conventional-type oropharyngeal SCC.


Laryngoscope | 2013

Population‐based analysis of prognostic indicators in sebaceous carcinoma of the head and neck

W. Walsh Thomas; Valerie A. Fritsch; Eric J. Lentsch

Due to the rarity of sebaceous carcinoma of the head and neck, few large series have been reported and prognostic factors remain largely undetermined. This study presents prognostic factors in survival in sebaceous carcinoma of the head and neck.


Annals of Otology, Rhinology, and Laryngology | 2014

Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.

Sam L. Oyer; Valerie A. Fritsch; Eric J. Lentsch

Objectives: We sought to determine the impact of histologic subtype on disease-specific survival (DSS) in cases of differentiated thyroid carcinoma. Methods: Adult patients with papillary thyroid carcinoma (PTC) or follicular thyroid carcinoma (FTC) were identified from the Surveillance, Epidemiology, and End Results (SEER) Database for the years 1988 to 2003. The patients were grouped according to tumor type (PTC or FTC), and their age, gender, tumor size and extension, and nodal or distant metastases were recorded. The Kaplan-Meier method was used to compare DSS rates on the basis of histologic subtype. Results: We identified 36,725 patients, of whom 77% were female and 23% were male; PTC was diagnosed in 91% of patients, and FTC in the remaining 9%. Patients with PTC were younger, were more likely to be female, and had smaller tumors with higher rates of regional metastases but fewer distant metastases than FTC patients (p < 0.0001 for all). When the cases were stratified by stage, FTC patients had a worse DSS than did PTC patients for all stages — except for stages III/IVA and IVC among patients more than 45 years of age. Conclusions: Follicular thyroid carcinoma portends a worse DSS than does PTC, even when the cases are controlled for stage. Consideration should be given to individual staging for these subtypes of differentiated thyroid carcinoma.


Laryngoscope | 2013

Squamous cell carcinoma of the uvula: an analysis of factors affecting survival.

Lewis J. Overton; Valerie A. Fritsch; Eric J. Lentsch

Uvular squamous cell carcinoma (SCC) is usually considered with soft palate tumors as an oropharyngeal cancer subsite. This investigation aims to determine whether the uvula itself is a high‐risk subsite in the oropharynx for primary squamous cell carcinomas.

Collaboration


Dive into the Valerie A. Fritsch's collaboration.

Top Co-Authors

Avatar

Eric J. Lentsch

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Joan E. Cunningham

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Anand K. Sharma

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Daniel Gerry

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Ramsay Camp

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Keisuke Shirai

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Lewis J. Overton

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Sam L. Oyer

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Terry A. Day

Medical University of South Carolina

View shared research outputs
Researchain Logo
Decentralizing Knowledge